SSTNIV, a syndecan-1-targeting peptide chimera, reverses immune suppression and inhibits myeloma progression.
Saved in:
| Title: | SSTN |
|---|---|
| Authors: | Jung O; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA. ojung@unmc.edu.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA. ojung@unmc.edu.; Department of Human Oncology and School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA. ojung@unmc.edu., Beauvais DM; Department of Human Oncology and School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.; Norcliffe Foundation Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA., Ibaan GL; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA., Wooldrik CC; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA., Flietner E; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI, USA., Choi S; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA. schoi@unmc.edu.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA. schoi@unmc.edu., Zhang J; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI, USA., Rapraeger AC; Department of Human Oncology and School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA. |
| Source: | Signal transduction and targeted therapy [Signal Transduct Target Ther] 2026 May 12; Vol. 11 (1). Date of Electronic Publication: 2026 May 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2059-3635 |
|---|---|
| DOI: | 10.1038/s41392-026-02709-1 |
